Waterborne Polyurethane Market - By Application (Coating, Sealant, Adhesive, Elastomer, Others), By End-Use Industry (Building & Construction, Automotive & Transportation, Bedding & Furniture, Electronics, Others) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 193
Status: Published
Report Code: ARI100616
The global waterborne polyurethanes market measurement is estimated at USD 1.7 billion in 2020 to USD 2.1 billion by way of 2027, at a CAGR of 5.2%. The developing demand for waterborne polyurethanes is due to the growing needs for innovative, environment friendly, and most economical products and the developing construction industry in the rising countries.
The demand for bedding has extended in the healthcare sector, owing to the pandemic. An upward shove in demand from a number of hospitals and care institutions for supplying these mattresses for the growing number of sufferers is boosting the consumption of waterborne polyurethanes in the manufacturing of these devices/equipment.
Driver: Substitution of solvent-based polyurethanes
Solvent-based polyurethanes are made up of liquefying sellers that evaporate when comes in contact with oxygen. Solvent-based polyurethanes emit toxic fumes that comprise dangerous free isocyanates, which can affect the respiratory system and be hazardous for bronchial asthma sufferers, children, and the elderly. It also emits VOCs (Volatile Organic Compounds) into the atmosphere. Breathing VOCs can irritate the eyes, nostril and throat, can purpose concern breathing and nausea, and can harm the central frightened gadget as properly as other organs. Some VOCs can cause cancer. Owing to the unsafe results of these emissions regulatory bodies have pressurized in creating environment-friendly products. Waterborne polyurethanes were developed as a result of the regulatory pressure on unsafe chemical emissions and are non-toxic. Waterborne polyurethanes are stable, easy-to-use, and exhibit homes similar to solvent-based systems.
Restrain: Volatility in the uncooked fabric prices
Raw materials used for manufacturing waterborne polyurethanes are primarily extracted from crude oil. Crude oil is one of the important sources of energy that accounted for 27.3% of the world primary strength consumption in 2020, according to the BP Statistical Review of Energy. The average crude oil spot charge reached USD 52 per barrel at the cease of December 2016 from a low of USD 29.8 per barrel at the quilt of January 2016. Crude oil fee is very tons on a recuperation course and stabilized in the range of USD 55 to USD 60 per barrel in 2017. However, due to COVID-19 in 2020, nearly all countries have banned each home and worldwide travel. This has prompted a big drop in demand for transportation fuel, which has similarly affected the crude oil prices. Owing to such fluctuating crude oil prices, raw fabric expenditures of waterborne polyurethanes are volatile.
Opportunity: Increasing consciousness about the dangerous consequences of chemical emissions from solvents
Various industries such as constructing & construction, car & transportation, bedding & furniture, and electronics use waterborne polyurethanes in the shape of coatings, adhesives, sealants, and elastomers. The demand for waterborne polyurethanes is developing in these industries owing to the growing attention of the hazardous results of chemical emissions from solvent-based polyurethanes. Solvent-based polyurethanes emit VOCs and HAPs into the environment. These VOCs and HAPs damage the people and the environments. These emissions can affect the respiratory gadget and be dangerous for bronchial asthma sufferers, children, and the elderly. Breathing VOCs can irritate the eyes, nostril and throat, can cause difficulty respiratory and nausea, and can damage the central apprehensive gadget as nicely as other organs. Some VOCs can additionally motive cancer. The increasing cognizance about the negative results of these emissions has driven a want for merchandise that are non-toxic and environment-friendly such as waterborne polyurethanes.
Challenge: Poor overall performance of waterborne polyurethanes compared to solvent-based polyurethanes
Solvent-based polyurethanes use essential solvents such as are butanone, cyclohexanone, ethyl acetate, and toluene. These organic solvents have a tendency to be exceptionally volatile and toxic, flammable and explosive, which is no longer solely dangerous, however also a risk to the surroundings and human health. As a result, waterborne polyurethanes have been developed that are non-toxic and environment friendly. Waterborne polyurethane coatings with low VOC emissions and proper product overall performance have drawn large public concern. However, due to the boundaries of the molecular structure of waterborne polyurethanes, it has some disadvantages, such as heat resistance, water resistance, solvent resistance, and negative gloss. The developers are working to improvise the overall performance of waterborne polyurethanes.
The sealant application segment to register the fastest increase at some stage in the forecast period. The constructing & building industry to be the largest end-use market for waterborne polyurethanes. APAC is projected to be the greatest waterborne polyurethanes market in the course of the forecast period. The waterborne polyurethanes market in APAC is projected to register the absolute best CAGR at some stage in the forecast period. The market in APAC is driven by the developing development and industrial activities, accelerated purchaser spending, and robust economic growth.
The key players profiled in this report include Covestro (Germany), DSM (Netherlands), BASF (Germany), R STAHL (Germany), Chemtura (the US), Dow Inc., (the US), H.B. Fuller (the US), Wanhua Chemical (China), SNP Inc., (the US), and KAMSONS Chemical Pvt. Ltd., (India). These players have adopted various organic as well as inorganic growth strategies between 2020 and 2020 to decorate their regional presence and meet the growing demand for waterborne polyurethanes from rising economies.
Analyst Commentary
The waterborne polyurethanes are used in quite a number end-use industries such as car & transportation, building & construction, bedding & furniture, electronics, and others. COVID-19 has impacted these industries.
The lockdown in quite a number countries and logistical restrictions have adversely impacted the car & transportation industry. Supply chain disruptions, group of workers unavailability, logistical restrictions, constrained availability of components, demand drop, low company liquidity, and shutdown of manufacturing due to lockdown in various nations have adversely affected the industry. OEMs, raw cloth suppliers, and other associated groups are compelled to reassess their techniques to cater to this enterprise at some point of this crisis period.
Residential and industrial development has come to a grinding halt owing to the pandemic. Waterborne polyurethanes demand from this zone is expected to be low to the medium for the duration of this crisis period. Some principal problems would be a extend in order shipments, supply chain restriction, manpower & gear shortage, and material shortage. Post conclusion of this crisis, the market is anticipated to revive, and demand is likely to expand for the waterborne polyurethanes market.
The demand for bedding has extended in the healthcare sector, owing to the pandemic. An upward shove in demand from a number of hospitals and care institutions for supplying these mattresses for the growing number of sufferers is boosting the consumption of waterborne polyurethanes in the manufacturing of these devices/equipment.
Segmentation
The sealant application segment to register the fastest increase at some stage in the forecast period.
Waterborne polyurethane primarily based sealants furnish tighter seals and varieties a flexible and elastomeric seam on curing. The UV resistant sealant offers super adhesion to most of the industrial materials. Waterborne polyurethane sealants are extra appropriate for various purposes owing to the formation of long-lasting water-proof seal on curing. Waterborne polyurethane sealants are used in street repair, plumbing, and building the place a high-strength, water-resistant seal is needed. They provide high stress recovery to maintain form after being bent or deformed, quick curing rates, and even adherence to non-primed concrete. These end-uses of waterborne polyurethane sealants are using market growth.
The constructing & building industry to be the largest end-use market for waterborne polyurethanes.
Waterborne polyurethanes have been at the epicentre of coating industry, supplying greener solutions to contemporary coating problems. This chemical is polyurethane dispersed in water. This reduces the dependence on solvent-based polyurethanes, supplying a better and environment-friendly alternative for current systems. Advantages like temperature curing and properly adhesion similarly reinforce the case for waterborne polyurethanes. It is regularly used in constructing and construction applications. Affordability of these versatile materials and the comfort they supply have made polyurethane aspects part of building & development industry, globally. In addition, the developing residential and commercial development activities in emerging economies such as India, China, Indonesia, Vietnam, Chile, and others are in addition driving consumption in this industry.
Regional Analysis
APAC is projected to be the greatest waterborne polyurethanes market in the course of the forecast period.
The waterborne polyurethanes market in APAC is projected to register the absolute best CAGR at some stage in the forecast period. The market in APAC is driven by the developing development and industrial activities, accelerated purchaser spending, and robust economic growth.
The latest COVID-19 pandemic is expected to impact the world car industry. The whole furnish chain is disrupted due to restrained grant of parts. For instance, Hubei province in China, which money owed for 8–10% of the Chinese auto production, was once severely impacted by way of pandemic. Chinese suppliers round the globe have placed manufacturing traces on halt or shut them down completely. The criminal and change restrictions, such as sealed borders, make bigger the scarcity of required parts. Such disruptions in grant chain are anticipated to affect the meeting of OEMs in Europe and North America.
BASF increased the production capacity of water-based polyurethane dispersions in Europe by 30% in January 2020 This strategy will allow the company to better serve its customers and meet the growing demand for water-based polyurethane dispersions.
In June 2020, DSM partnered with TLF (Germany), a globally involved business providing leather and related industries with specialty chemicals. This partnership involves the supply of cutting-edge, sustainable waterborne polyurethane dispersion systems as well as R&D. DSM and TFL are able to further unlock the value of sustainable leather finishes and improve their respective market positions by collaborating at various points in the value chain.
Covestro developed polyurethane dispersions called Impraperm DL 5249 and Impraperm DL 5310.0 in July 2018. These are used as textile coatings and, using waterborne technology, enable efficient waterproofing and breathability of coatings.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Vitamin D Therapy Market
Chapter 5. Global Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
5.1. Global Vitamin D Therapy Market Share, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
5.1.1. Oral
5.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
5.1.2. Parental
5.1.2.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 6. Global Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
6.1. Global Vitamin D Therapy Market Share, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
6.1.1. Prescription Drugs
6.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
6.1.2. Over-the-counter Drugs
6.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 7. Global Vitamin D Therapy Market Overview, By Age group, 2015 - 2027(Kiloton) (USD Million)
7.1. Global Vitamin D Therapy Market Share, By Age group, 2015 - 2027 (Kiloton) (USD Million)
7.1.1. Children
7.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
7.1.2. Adults
7.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
7.1.3. Senior Adults
7.1.3.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 8. Global Vitamin D Therapy Market Overview, By Application, 2015 - 2027(Kiloton) (USD Million)
8.1. Global Vitamin D Therapy Market Share, By Application, 2015 - 2027 (Kiloton) (USD Million)
8.1.1. Osteoporosis
8.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
8.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.2. Rickets
8.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.3. Muscle weakness
8.1.3.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.4. Autoimmune disorders
8.1.4.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.5. Skin diseases
8.1.5.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.6. Others
8.1.6.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 9. Global Vitamin D Therapy Market Overview, By Geography, 2015 - 2027(Kiloton) (USD Million)
9.1. Global Vitamin D Therapy Market Share, By Geography, 2015 - 2027(Kiloton) (USD Million)
9.1.1. Market Type and projections, by Countries, 2015 - 2027 (Kiloton) (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 10. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(Kiloton) (USD Million)
10.1. North America Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.2. North America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.3. North America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.4. North America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
10.1.5. North America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
10.1.6. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1. U.S. Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.2. U.S. Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.3. U.S. Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.4. Other Segment
10.1.6.2. Canada Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.2. Canada Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.3. Canada Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.4. Other Segment
10.1.6.3. Mexico Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.2. Mexico Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.3. Mexico Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.4. Other Segment
Chapter 11. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(Kiloton) (USD Million)
11.1. Europe Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.2. Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
11.1.3. Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
11.1.4. Europe Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
11.1.5. Europe Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
11.1.6. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.1.2. Germany Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.1.3. Germany Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.1.4. Other Segments
11.1.6.2. France
11.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.2.2. France Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.2.3. France Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.2.4. Other Segments
11.1.6.3. UK
11.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.3.2. UK Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.3.3. UK Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.3.4. Other Segments
11.1.6.4. Italy
11.1.6.4.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.4.2. Italy Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.4.3. Italy Vitamin D Therapy Market Overview, By Purchasing Pattern2015 - 2027(Kiloton) (USD Million)
11.1.6.4.4. Other Segments
11.1.6.5. Spain
11.1.6.5.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.5.2. Spain Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.5.3. Spain Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.5.4. Other Segments
11.1.6.6. Rest of Europe
11.1.6.6.1. Market Type and projections, 2015 – 2027
11.1.6.6.2. Rest of Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.6.3. Rest of Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.6.4. Other Segments
Chapter 12. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
12.1. Asia Pacific Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.2. Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
12.1.3. Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.4. Asia Pacific Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
12.1.5. Asia Pacific Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
12.1.6. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1. India
12.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1.2. India Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.1.3. India Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1.4. Other Segments
12.1.6.2. China
12.1.6.2.1. Market Type and projections, 2015 - 2027(Kiloton) (USD Million)
12.1.6.2.2. China Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.2.3. China Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.2.4. Other Segments
12.1.6.3. Japan
12.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.3.2. Japan Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.3.3. Japan Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
12.1.6.3.4. Other Segments
12.1.6.4. South Korea
12.1.6.4.1. Market Type and projections, 2015 - 2027(Kiloton) (USD Million)
12.1.6.4.2. South Korea Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.4.3. South Korea Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.4.4. Other Segments
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.5.2. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.5.3. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.5.4. Other Segments
Chapter 13. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
13.1. Middle East & Africa Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.2. Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.3. Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.4. Middle East & Africa Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
13.1.5. Middle East & Africa Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
13.1.6. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.2. GCC Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.3. GCC Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.4. Other Segments
13.1.6.2. South Africa
13.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.2. South Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.3. South Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.4. Other Segments
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.2. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.3. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.4. Other Segments
Chapter 14. South America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
14.1. South America Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
14.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.2. South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.3. South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.4. South America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
14.1.5. South America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
14.1.6. South America Vitamin D Therapy Market Overview, By Countries, 2015- 2026 (Kiloton) (USD Million)
14.1.7. Brazil
14.1.7.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.2. Brazil Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.3. Brazil Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.4. Other Segments
14.1.8. Argentina
14.1.8.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.2. Argentina Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.3. Argentina Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.4. Other Segments
14.1.9. Rest of South America
14.1.9.1. Market Type and projections, 2015 – 2027
14.1.9.2. Rest of South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.9.3. Rest of South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.9.4. Other Segments
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New Technology development
Chapter 16. Key Vendor Analysis
16.1. Sanofi
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Mice Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. GlaxoSmithKline plc
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Mice Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Pfizer Inc
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Mice Benchmarking
16.3.4. Recent initiatives
16.4. Merck & Co., Inc
16.5. Torrent Pharmaceuticals
16.6. Novartis International AG
16.7. Alkem Laboratories
16.8. Sun Pharmaceuticals Industries Ltd.
16.9. Cadila Healthcare Ltd.
16.10. Others
Chapter 17. Vitamin D Therapy Market Cost Analysis
17.1. Vitamin D Therapy Market Key Technology Analysis
17.1.1. Key Technology
17.1.2. Price Trend of Key Technology
17.1.3. Key Suppliers of Technology
17.1.4. Market Concentration Rate of Technology
17.1.5. Technology
17.1.6. Labor Cost
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Vitamin D Therapy Market Industrial Chain Analysis
18.2. Upstream Technology Sourcing
18.3. Technology Sources of Vitamin D Therapy Market Major Manufacturers in 2021
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Type
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Vitamin D Therapy Market share, By Route of Administration, 2020 & 2027 (%)
10. Global Vitamin D Therapy Market share, by Oral, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
11. Global Vitamin D Therapy Market share, by Parental, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
12. Global Vitamin D Therapy Market share, By Purchasing Pattern, 2020 & 2027 (%)
13. Global Vitamin D Therapy Market share, by Prescription Drugs, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14. Global Vitamin D Therapy Market share, by Over-the-counter Drugs, By Purchasing Pattern 2015 - 2027 (Kiloton) (USD Million)
15. Global Vitamin D Therapy Market share, By Age group, 2020 & 2027 (%)
16. Global Vitamin D Therapy Market share, by Children, By Age group, 2015 - 2027 (Kiloton) (USD Million)
17. Global Vitamin D Therapy Market share, by Adults, By Age group 2015 - 2027 (Kiloton) (USD Million)
18. Global Vitamin D Therapy Market share, by Senior Adults, By Age group 2015 - 2027 (Kiloton) (USD Million)
19. Global Vitamin D Therapy Market Overview, By Application, 2020 & 2027 (%)
20. Global Vitamin D Therapy Market share, by Osteoporosis, By Application 2015 - 2027 (Kiloton) (USD Million)
21. Global Vitamin D Therapy Market share, by Rickets, By Application 2015 - 2027 (Kiloton) (USD Million)
22. Global Vitamin D Therapy Market share, by Muscle weakness, By Application 2015 - 2027 (Kiloton) (USD Million)
23. Global Vitamin D Therapy Market share, by Autoimmune disorders, By Application 2015 - 2027 (Kiloton) (USD Million)
24. Global Vitamin D Therapy Market share, by Skin diseases, By Application 2015 - 2027 (Kiloton) (USD Million)
25. Global Vitamin D Therapy Market share, by Others, By Application 2015 - 2027 (Kiloton) (USD Million)
26. Global Vitamin D Therapy Market share, by region, 2020 & 2027 (%)
27. Global Vitamin D Therapy Market share, by region, 2015 - 2027(Kiloton) (USD Million)
28. North America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
29. North America Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
30. U.S. Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
31. Canada Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
32. Mexico Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
33. Europe Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
34. Europe Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
35. Spain Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
36. UK Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
37. Italy Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
38. Germany Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
39. France Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
40. Rest of Europe Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
41. Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
42. Asia-Pacific Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
43. China Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
44. India Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
45. Australia Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
46. Japan Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
47. Rest of Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
48. Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
49. Middle East & Africa Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
50. GCC Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
51. South Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
52. Rest Of Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
53. South America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
54. Brazil Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
55. Mexico Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
56. Argentina Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
57. Rest Of South America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Vitamin D Therapy Market, 2015-2027 (Kiloton) (USD Million)
4. Vitamin D Therapy requirement, by country, 2015-2027, (Kiloton) (USD Million)
5. North America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
6. North America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
7. North America Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
8. North America Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
9. Europe Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
10. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
11. Europe Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
12. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
13. Europe Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
14. Asia Pacific Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
15. Asia Pacific Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Revenue, USD Million)
16. Asia Pacific Vitamin D Therapy Market, By Age group, 2015-2027 (Revenue, USD Million)
17. Asia Pacific Vitamin D Therapy Market, By Application, 2015-2027 (Revenue, USD Million)
18. Middle East & Africa Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
19. Middle East & Africa Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
20. Middle East & Africa Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
21. Middle East & Africa Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
22. South America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
23. South America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
24. South America Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
25. South America Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
26. Global Vitamin D Therapy Market, Company Market Share, 2020 - 2027 (%)
27. Sanofi: Product Benchmarking
28. Sanofi: Financial Performance
29. GlaxoSmithKline plc: Product Benchmarking
30. GlaxoSmithKline plc: Financial Performance
31. Pfizer Inc.: Product Benchmarking
32. Pfizer Inc.: Financial Performance
33. Merck & Co., Inc.: Product Benchmarking
34. Merck & Co., Inc.: Financial Performance
35. Torrent Pharmaceuticals: Product Benchmarking
36. Torrent Pharmaceuticals: Financial Performance
37. Novartis International AG: Product Benchmarking
38. Novartis International AG: Financial Performance
39. Alkem Laboratories: Product Benchmarking
40. Alkem Laboratories: Financial Performance
41. Sun Pharmaceuticals Industries Ltd.: Product Benchmarking
42. Sun Pharmaceuticals Industries Ltd.: Financial
43. Cadila Healthcare Ltd.: Product Benchmarking
44. Cadila Healthcare Ltd.: Financial Performance
The Leading Key Players in Waterborne Polyurethane Market
Covestro (Germany)
DSM (Netherlands)
BASF (Germany)
R STAHL (Germany)
Chemtura (the US)
Dow Inc. (the US)
H.B. Fuller (the US)
Wanhua Chemical (China)
SNP Inc. (the US)
KAMSONS Chemical Pvt. Ltd. (India).
